Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adamis Pharmaceuticals Corporation (ADMP)
  7. Financials

ADMP

Adamis Pharmaceuticals Corporation
0.1077
0.003 (2.87%)
Upgrade to Real-Time

Adamis Pharmaceuticals Corporation (ADMP) Fundamentals
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
SHARE INFORMATION
Market Cap$ 17,430,798
Shares Outstanding166,483,265
Float165,911,771
Percent Float99.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 4,850,726
Latest Fiscal EPS$ -0.19
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions72
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months66,521
Institutional Holdings Percent19.6%
Institutional Sold Previous 3 Months243,725
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent5.7
Insider Sold Previous 3 Months-
Insider Shares Owned8,569,137
TRADING INFO
52 Week High$ 0.68
52 Week Low$ 0.10
52 Week High Change$ -83.63
21 Day Moving Average$ 0.1737
21 Day Extended Moving Average$ 0.157131
50 Day Moving Average$ 0.2022
50 Day Extended Moving Average$ 0.183934
200 Day Moving Average$ 0.265028
200 Day Extended Moving Average$ 0.281022
10 Day Average Volume1,542,735
20 Day Average Volume2,765,682
30 Day Average Volume2,054,766
50 Day Average Volume1,442,380
Alpha-0.010645
Beta1.2623
Standard Deviation0.327902
R20.042978
7 Day Price Change$ -0.02
7 Day Percent Change-16.04%
21 Day Price Change$ -0.1201
21 Day Percent Change-53.43%
30 Day Price Change$ -0.1699
30 Day Percent Change-61.87%
Month to Date Price Change$ -0.1201
Month to Date Percent Change-53.43%
Quarter to Date Price Change$ -0.0646
Quarter to Date Percent Change-38.16%
180 Day Price Change$ -0.1532
180 Day Percent Change-59.4%
200 Day Price Change$ -0.2231
200 Day Percent Change-68.06%
Year to Date Price Change$ -0.0646
Year to Date Percent Change-38.16%

Adamis Pharmaceuticals Corporation (ADMP) Key Ratios

PROFITABILITY
EBIT Margin-2,090.6%
EBITDA Margin-1,988.5%
Pre-Tax Profit Margin-236.2%
Profit Margin Count0.0%
Gross Margin-30.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 4,850,726
Revenue Per Share$ 0.0291
Revenue (3 Years)$ -41.21
Revenue (5 Years)$ -18.73
FINANCIAL STRENGTH
Price to Tangible Book-20.90
Total Debt To Equity0.20
Int Coverage-79.70
Current Ratio0.80
Leverage Ratio2.90
Quick Ratio0.20
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 16,109,304
Price to Sales3.5934
Price to Free Cash-0.60
PE High Last 5 Years-2.60
Price To Book6.40
Price To Cash Flow0.00
PE Low Last 5 Years-2.20
Price to Tangible Book-20.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.40
Invoice Turnover7.60
Assets Turnover0.20
Return Assets-112.54
Return on Equity-224.32
Return on Capital-164.56

Adamis Pharmaceuticals Corporation (ADMP) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEODavid J. Marguglio
Emplyoees15
Last AuditUE
CIK0000887247
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address11682 El Camino Real
Suite 300
San Diego, CA 92130
Websitehttps://www.adamispharmaceuticals.com
Facsimile-
Telephone+1 858 997-2400
Emailinfo@adamispharma.com


Your Recent History
NASDAQ
ADMP
Adamis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.